The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test

被引:5
|
作者
Berthelsen, Mona [1 ]
Berstad, Paula [1 ,7 ]
Randel, Kristin R. [1 ]
Hoff, Geir [1 ,2 ,3 ]
Natvig, Erik [1 ]
Holme, Oyvind [4 ,5 ]
Botteri, Edoardo [1 ,6 ]
机构
[1] Canc Registry Norway, Sect Colorectal Canc Screening, POB 5313 Majorstuen, N-0304 Oslo, Norway
[2] Telemark Hosp Trust, Dept Res & Dev, Ulefossvegen 55, N-3710 Skien, Norway
[3] Univ Oslo, Inst Clin Med, POB 1171 Blindern, N-0318 Oslo, Norway
[4] Sorlandet Hosp, Dept Med, POB 416 Lundsiden, N-4604 Kristiansand, Norway
[5] Univ Oslo, Inst Hlth & Soc, POB 1130 Blindern, N-1130 Oslo, Norway
[6] Canc Registry Norway, Dept Res, POB 5313 Majorstuen, N-0304 Oslo, Norway
[7] Canc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway
关键词
Colorectal cancer screening; Driving time; Faecal immunochemical test; Participation; Sigmoidoscopy; BREAST-CANCER; DISPARITIES; POPULATION; PREDICTORS; BARRIERS;
D O I
10.1016/j.canep.2022.102244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High participation rates are important for a colorectal cancer (CRC) screening programme to be effective. Having a long travelling distance to screening centres may impede participation.Methods: We analysed the association between driving time from home address to screening centre and participation among individuals invited to screening with faecal immunochemical test (FIT) (n = 68,624) or sigmoidoscopy (n = 46,076) in a randomized trial in Norway in 2012-17. Two screening centres were involved. We fitted multiple logistic regression models, adjusted for demographic, socioeconomic and health characteristics, and reported odds ratios (OR) with 95% confidence intervals (CI). Results: Participation rates were 58.9 % (n = 40,445) for FIT and 51.9 % (n = 23,911) for sigmoidoscopy. In sigmoidoscopy, participation was 56.9 % and 47.9 % in those living < 20 and > 60 min by car from the screening centres, respectively. For each 10 min driving time increase, OR for participating in sigmoidoscopy screening was 0.93 (95 % CI 0.91-0.95). There was a significant difference between the two screening centres (p-value for heterogeneity <0.001). Participation in FIT screening were 61.2 % and 57.1 % in those with < 20 and > 60 min driving time, respectively, and the OR was 0.98 (95 % CI 0.96-0.99) for each 10 min increase (heterogeneity between screening methods, P-value <0.001). Among those with a positive FIT, compliance to colonoscopy was higher in those living < 20 compared to > 60 min from the centres (95.1 % vs. 92.9 %, respectively, OR 0.86; 95 % CI 0.77-0.93 for each 10 min increase).Conclusions: Driving time to screening centre was a significant predictor of participation, mainly in sigmoidoscopy. There were local differences in the impact of driving time on participation. Driving time also affected compliance to colonoscopy after a positive FIT. When planning a CRC screening programme, one should consider offering people living far from screening sites special assistance to facilitate their participation.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Colorectal cancer screening using immunochemical faecal occult blood testing in Japan
    Saito, Hiroshi
    JOURNAL OF MEDICAL SCREENING, 2006, 13 : S6 - S7
  • [42] Feasibility of immunochemical faecal occult blood testing for colorectal cancer screening in Bulgaria
    Dimova, Rositsa Tsvetanova
    Dimitrova, Donka Dimitrova
    Levterova, Boriana Angelova
    Dimov, Rossen Stoyanov
    Semerdjieva, Maria Atanasova
    Tamovska, Miglena Frantova
    Stoyanova, Rumiana Gencheva
    JOURNAL OF BUON, 2015, 20 (02): : 413 - 420
  • [43] Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test
    Tan, Wah Siew
    Tang, Choong Leong
    Koo, Wen Hsin
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (04) : 220 - 223
  • [44] Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years
    Idigoras Rubio, Isabel
    Arana-Arri, Eunate
    Portillo Villares, Isabel
    Bilbao Iturribarrria, Isabel
    Martinez-Indart, Lorea
    Imaz-Ayo, Natale
    de la Cruz, Marta
    de Castro, Visitacion
    Lopez de Munain, Arantza
    Torrejon Perez, Idoia
    Gutierrez-Ibarluzea, Inaki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (02) : 197 - 204
  • [45] Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
    Manon van der Vlugt
    Esmée J Grobbee
    Patrick MM Bossuyt
    Evelien Bongers
    Wolfert Spijker
    Ernst J Kuipers
    Iris Lansdorp-Vogelaar
    Marie-Louise Essink-Bot
    Manon C W Spaander
    Evelien Dekker
    British Journal of Cancer, 2017, 116 : 44 - 49
  • [46] Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
    van der Vlugt, Manon
    Grobbee, Esmee J.
    Bossuyt, Patrick M. M.
    Bongers, Evelien
    Spijker, Wolfert
    Kuipers, Ernst J.
    Lansdorp-Vogelaar, Iris
    Essink-Bot, Marie-Louise
    Spaander, Manon C. W.
    Dekker, Evelien
    BRITISH JOURNAL OF CANCER, 2017, 116 (01) : 44 - 49
  • [47] Colorectal cancer screening through the faecal occult blood test
    Diaz Tasende, J.
    Martin Gabriel, J. C.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2008, 100 (06) : 315 - 319
  • [48] Limitations of the faecal occult blood test in screening for colorectal cancer
    Delcò, F
    Sonnenberg, A
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (02): : 119 - 126
  • [49] Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population
    W.-P. Fu
    M.-H. Kam
    W.-M. Ling
    S.-F. Ong
    N. Suzannah
    Kong-Weng Eu
    Techniques in Coloproctology, 2009, 13 : 225 - 230
  • [50] An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme
    Kelley, L.
    Swan, N.
    Hughes, D. J.
    COLORECTAL DISEASE, 2013, 15 (09) : E512 - E521